Arcutis Biotherapeutics, Inc. ARQT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s deferred tax assets and other non-current assets?
- Arcutis Biotherapeutics, Inc. (ARQT) reported deferred tax assets and other non-current assets of $2.3M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s deferred tax assets and other non-current assets increased by 285.2% year-over-year, from $596K to $2.3M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 78.6% compound annual growth rate (CAGR), from $78K to $1.42M.